A study led by researchers at Mass General Cancer Center found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity. “We are entering an era in which we have the tools to make cancer therapies more precise and more personalized,” said corresponding author Justin Gainor, MD, program director of the Center for Thoracic Cancers at Mass General Cancer Center. Read more: http://spklr.io/6041s2jR
Mass General Cancer Center
Hospitals and Health Care
Boston, Massachusetts 4,683 followers
Mass General Cancer Center in Boston, Massachusetts, is proud to be one of the top-ranked Cancer Centers in the US.
About us
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States. U.S. News & World Report consistently ranks the Mass General Cancer Center as one of the top cancer centers in the country. Its nurses were the first in Massachusetts to achieve Magnet status from the American Nurses Credentialing Center in recognition of the hospital's exceptional nursing care. Known for providing customized, innovative treatments and compassionate care to both adults and children, the Cancer Center comprises more than 37 treatment programs within 29 fully integrated, multidisciplinary disease centers and a vast array of support and educational services. Its network of affiliations extends throughout New England and the southeastern U.S. The Cancer Center’s commitment to eradicating cancer is fueled by scientific investigation conducted as part of one of the largest hospital-based research programs in the nation. Through a powerful synergy between laboratory scientists and bedside physicians, the Mass General Cancer Center fosters innovation in all phases of cancer research. Physician investigators conduct nearly 400 clinical trials annually. The Massachusetts General Hospital Cancer Center is proud to be a founding member of a Harvard Medical School consortium designated by the National Cancer Institute as a comprehensive cancer center. This prestigious seven-member center forms the largest cancer research collaboration in the country. The promising new treatments developed through this partnership are revolutionizing the future of cancer medicine.
- Website
-
https://www.massgeneral.org/cancer-center
External link for Mass General Cancer Center
- Industry
- Hospitals and Health Care
- Company size
- 5,001-10,000 employees
- Headquarters
- Boston, Massachusetts
- Type
- Nonprofit
- Specialties
- Oncology, hematology, cancer care, surgical oncology, radiation oncology, and medical oncology
Locations
-
Primary
32 Fruit St
Boston, Massachusetts 02114, US
Employees at Mass General Cancer Center
Updates
-
Tumor-infiltrating lymphocytes therapy (TIL) is a form of immunotherapy. TIL cancer therapy boosts your body's natural immune response to improve your ability to fight cancer. Doctors take a sample from one of your tumors and extract TILs that have already entered the tumor to fight it. Your body produces TILs as a response to cancer. They are specially built to fight your specific cancer. Once the TILs are collected, they're sent to a lab where they're multiplied until there are huge numbers (often billions) of them. Next, doctors prepare your body for the TIL treatment with a round of chemotherapy. Once you're ready, the TILs are put back into your body with an infusion and you're given an immune-boosting therapy called interleukin 2. The TILs will then naturally go where the cancer is and attack it. Learn more: http://spklr.io/6044smjO
-
-
When Donald Lawrence, MD, clinical director for the Center for Melanoma at Mass General Cancer Center, first treated Matteo Abbruzzese for melanoma in 2013, therapies were limited. Now, thanks to medical advances that started with cases like Teo’s, Dr. Lawrence sees potential for melanoma to be one of the most curable cancers. Read more: http://spklr.io/6046snH8. #MassGeneralGiving
-
-
The US Food and Drug Administration approved a blood test to be used for colorectal cancer screening among average-risk adults ages 45 and older. Daniel Chung, MD, Director, High-Risk GI Cancer Clinic, shares with CNN, “The FDA’s approval of the Shield blood test marks a tremendous leap forward, offering a compelling new solution to close this gap. This decision will help make screening tests more broadly accessible.” Chung said, “With increased screening rates and early cancer detection, many more lives can be saved.” Read more: http://spklr.io/6040surA
-
A new rapid genotyping test cuts brain tumor diagnosis time from 10 days to 2, avoiding invasive biopsies. It accurately identified tumors in 42% of cases with zero false positives. Learn how this collaboration is improving patient care. http://spklr.io/6040sJuo
Rapid Test of Cerebrospinal Fluid Decreases Time to Diagnosis for Brain Tumors | Mass General Brigham
massgeneralbrigham.org
-
Stay updated on the latest in cancer treatment with our comprehensive clinical review of advances in immuno-oncology. Learn about molecularly-targeted therapies and immune system mobilization. Plus, join our optional session on managing immunotherapy toxicities, "Sink or Swim," for an in-depth look at common and uncommon toxicities. Register now: http://spklr.io/6041Shd1. #CancerTreatment #ImmunoOncology #MedicalEducation
-
-
Mass General Brigham is operational. Mass General Cancer Center is open and seeing patients. All scheduled appointments and procedures will happen as planned on Monday, July 22. 𝐔𝐩𝐝𝐚𝐭𝐞: 𝐉𝐮𝐥𝐲 𝟏𝟗 - 𝟏𝟏:𝟎𝟏 𝐩.𝐦. Mass General Brigham mobilized incident command and other leadership teams across the organization to manage our response to the CrowdStrike incident. As part of this response, we have also deployed hundreds of technicians to our hospitals, healthcare centers, and outpatient clinics to restore access to the systems and devices that were impacted by the software failure early this morning. The hard work since the very early hours by our response teams and staff allowed our clinics and emergency departments to remain open today for those with urgent health concerns, in addition to the many patients currently admitted in our hospitals. We are doing everything possible to restore the electronic systems that support our patient care delivery across our system. Our teams will continue to work throughout the night to implement solutions and, at this time, we expect to be operational tomorrow. We apologize for the inconvenience that this has caused to the many patients who had scheduled visits with us today. ----------------------------------------------------------------- A major worldwide software outage has affected many of our systems at Mass General Brigham, as well as many major businesses across the country. Due to the severity of this issue, all previously scheduled non-urgent surgeries, procedures, and medical visits are cancelled today. Mass General Cancer Center remains open to provide care to patients with urgent health concerns in our clinics and emergency departments, and we continue to care for all patients currently receiving care in our hospitals. We have dedicated every available resource to resolve this issue as quickly as possible, and we apologize for the inconvenience this has caused our patients. It is our highest priority to ensure that our patients receive the safest care possible.
-
-
Marcela Maus, MD, PhD, director of the Cellular Immunotherapy Program, and Bryan Choi, MD, PhD, associate director of Brain Tumor Immunology and Immunotherapy, are changing the way glioblastoma is treated with a next generation CAR T therapy research study. They are infusing genetically modified white blood cells directly into the fluid surrounding the brain. The second patient in the trial, Tom Fraser from upstate New York, was given just six months to live before he was introduced to the trial. It has now been almost three years since his initial diagnosis. Read more about the trial and Tom's story from New York Magazine: http://spklr.io/6040SsK6
Good News About Brain Cancer
nymag.com
-
We are pleased to share that Massachusetts General Hospital is ranked #11 on the latest list of Best Hospitals for Cancer by U.S. News & World Report. A big thank you to all our physicians, nurses and staff who make a difference in our patients’ lives every day! Learn more about the latest cancer treatments and technologies being utilized at Mass General Cancer Center: http://spklr.io/6043SUH5
-
-
We are excited to share that our community location at Emerson Health in Concord, MA has a new linear accelerator (LINAC) offering a diverse range of high-precision radiation therapy treatment options, advanced imaging and more flexibility in patient setups. In this picture from left to right: Ron Neal, RTT, Lena Stamoulis, RTT, John McGrath, MD, medical director of the Massachusetts General Hospital Department of Radiation Oncology at Emerson Health and Maria Meimaris, RTT. http://spklr.io/6048S5jO
-